cro.directory
← Home
Sussex Research Laboratories Inc. logo

Sussex Research Laboratories Inc.

Global leader in carbohydrate synthesis and glycan-based drug delivery solutions for discovery through manufacturing.

Global leader in custom glycan, glycopeptide, and glycoconjugate synthesis for drug discovery and development. Offers CRO and CDMO services spanning preclinical R&D, custom carbohydrate synthesis, antibody development, and targeting ligand design with over 25 years of expertise. Headquartered in Canada.

Phases

Indications / Therapeutic Areas

Services

Modalities

About this organization

Overview

Sussex Research Laboratories Inc. is a specialized contract research and manufacturing organization focused on glycoscience—the study of carbohydrates (glycans) and their roles in biological processes. The company serves as a global leader in carbohydrate synthesis, offering both custom synthesis services and an extensive portfolio of pre-made glycan-based products.

Core Services

Glycan Synthesis & Development

  • Scalable, cost-effective synthesis of simple modified monosaccharides (e.g., GalNAc targeting ligands) to complex oligosaccharides (e.g., Sialyl Lewis X)
  • Expertise in hepatic (GalNAc) and extra-hepatic drug delivery strategies
  • Support for oligonucleotide, protein, lipid, and small-molecule-based applications

Glycopeptides & Peptides

  • Over 20 years of leadership in glycopeptide synthesis
  • Synthetic tumor-associated carbohydrate antigens (TACA) based on mucins, PSGL-1 mimetics, and glycopolypeptides
  • World's largest inventory of well-defined glycoamino acid building blocks
  • Expertise in glycated (fructosylated), glycolipid, lipid, and macrocyclic peptides

Antibody Development

  • Carbohydrate-based antigen production for antibody screening and generation
  • Glycan, glycopeptide, and glycolipid antigens with BSA, OVA, CRM, or KLH carrier protein conjugates

Targeting Ligands

  • Cell-specific carbohydrate ligands (GalNAc, sialic acid-containing glycans) targeting lectin/carbohydrate-mediated drug delivery
  • Receptor targeting: ASGPR, Galectins, Siglecs, Mannose-6-phosphate Receptor, Influenza HAs, Mannose Receptor (CD206)
  • Applications in RNA and difficult therapeutic molecule delivery to specific tissues

Preclinical & GMP Manufacturing Support

  • Connection to trusted network for pre-clinical and GMP manufacturing scale-up
  • Transition support from development to large-scale production

Quality & Compliance

  • ISO 9001:2015 certified
  • Rigorous quality control protocols throughout synthesis
  • Certificate of Analysis and analytical data documentation provided

Market Position

  • Over 1,000 clients worldwide
  • Over 25 years of industry experience
  • Made in Canada with international recognition
  • Expertise honed over decades in glycoscience research

Certifications

AuthorityIdentifierSource
ISOISO 9001:2015View

Locations

  • Headquarters

    Canada

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/sussex-research.md